The U.S. ultrasound systems market continues to be one of the most important segments of diagnostic imaging, supported by rising procedure volumes, wider clinical use, and growing adoption of advanced imaging technologies. Based on the provided market assessment, the U.S. ultrasound systems market increased from $1,735.5 million in 2020 to an estimated $2,432.4 million in 2026. This growth reflects steady demand across hospitals, diagnostic imaging centers, specialty clinics, emergency care settings, and point-of-care environments.
By 2026, the market is being shaped by three major forces: the expansion of point-of-care ultrasound, the integration of artificial intelligence into imaging workflows, and the increasing need for faster, cost-effective diagnostic tools. Procedure volume is also expanding, with the total number of U.S. ultrasound procedures estimated at 95.77 million in 2026. The largest patient group remains adults aged 18-64, followed by people aged 65 and above, showing the role of ultrasound in both routine diagnosis and age-related disease management.
Explore BIS Research’s Surgical Procedure Volume Database and ultrasound systems market insights to assess demand by procedure type, application, patient group, and care setting.
.png)
GE HealthCare remains one of the strongest players in the U.S. ultrasound systems market because of its wide product coverage across general imaging, women’s health, cardiology, and point-of-care ultrasound. Its competitive strength lies in scale, brand trust, clinical workflow integration, and a broad installed base across U.S. healthcare facilities.
The company is especially well positioned in portable and point-of-care ultrasound. As healthcare delivery moves closer to the bedside, emergency room, ICU, ambulance, outpatient, and home-care settings, GE HealthCare’s handheld and portable systems support faster clinical decisions. This aligns directly with one of the market’s key growth drivers: the rising adoption of point-of-care ultrasound systems.
Philips is another major competitor, with a strong presence in premium ultrasound, cardiovascular imaging, general imaging, obstetrics and gynecology, and point-of-care applications. Its key advantage is the combination of high-quality imaging, digital workflow tools, and AI-supported automation.
In the U.S. market, Philips benefits from demand for systems that improve consistency, reduce operator burden, and support faster reporting. These strengths are particularly relevant as ultrasound volumes rise and imaging departments face workforce pressure. Philips’ position is also supported by the importance of cardiology and general imaging, both of which remain major application areas in the market.
Siemens Healthineers competes strongly through its ACUSON ultrasound portfolio, with emphasis on image quality, automation, AI-assisted measurements, and workflow efficiency. Its strategy is closely aligned with the market shift toward smarter systems that reduce variability between users.
The company’s competitive positioning is strongest in advanced diagnostic imaging, cardiovascular ultrasound, obstetrics, vascular imaging, and high-performance hospital-based systems. As U.S. providers look for systems that support faster exams and more standardized outcomes, Siemens Healthineers is well placed in the premium and advanced ultrasound segment.
Canon Medical Systems is a key player in the U.S. ultrasound systems market through its Aplio ultrasound portfolio. Canon’s strengths include image quality, ergonomic design, advanced imaging applications, and workflow-focused features. Its systems are positioned for general imaging, radiology, vascular, women’s health, and other clinical specialties.
Canon’s competitive edge lies in supporting clinicians with high-resolution imaging and tools designed to improve diagnostic confidence. In a market where general imaging remains a leading application area, Canon’s broad clinical utility gives it a strong position among hospitals and imaging centers.
Fujifilm, especially through Fujifilm Sonosite, has a strong position in portable and point-of-care ultrasound. Its product strength is centered on durable, easy-to-use systems designed for bedside care, emergency medicine, critical care, anesthesia, musculoskeletal imaging, and procedural guidance.
This makes Fujifilm particularly relevant in the shift toward decentralized ultrasound use. While standalone systems held the largest share in 2020, the provided market data indicates growing adoption of portable and handheld ultrasound systems. Fujifilm’s focus on mobility, reliability, and clinician-friendly design supports its competitive role in this transition.
Request a quote to benchmark leading ultrasound system vendors, portfolios, and market opportunities in the U.S.
The top five companies lead because they address the most important buying priorities in the U.S. market: image quality, workflow efficiency, portability, AI integration, application coverage, and clinical reliability. From 2020 to 2026, the market’s growth is not only about selling more systems. It is also about helping healthcare providers scan faster, diagnose earlier, and expand ultrasound use across more care settings.
By 2026, GE HealthCare, Philips, Siemens Healthineers, Canon Medical Systems, and Fujifilm remain the key companies shaping the U.S. ultrasound systems market. Their competitive positions are built on strong portfolios, trusted brands, and the ability to respond to the industry’s shift toward smarter, portable, and more accessible ultrasound imaging.
Schedule a call with our Analyst to discuss your ultrasound systems market strategy, procedure-volume data needs, and competitive intelligence requirements.
